Role of Nucleotide-Binding Oligomerization Domain-Containing (NOD) 2 in Host Defense during Pneumococcal Pneumonia

Tijmen J Hommes1,2, Miriam H van Lieshout1,2, Cornelis van 't Veer1,2

  • 1Center for Experimental and Molecular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.

Plos One
|December 18, 2015
PubMed

Insights

Nucleotide-binding oligomerization domain-containing (NOD) 2 does not significantly impact host defense in most pneumococcal pneumonia models. However, NOD2 deficiency impairs clearance of unencapsulated Streptococcus pneumoniae, suggesting the bacterial capsule hinders NOD2 recognition.

Area of Science:

  • Immunology
  • Microbiology
  • Infectious Diseases

Background:

  • Streptococcus pneumoniae is a primary cause of community-acquired pneumonia.
  • Nucleotide-binding oligomerization domain-containing (NOD) 2 is a cytosolic pattern recognition receptor that detects bacterial peptidoglycans.

Purpose of the Study:

  • To investigate the role of NOD2 in the host immune response during pneumococcal pneumonia.
  • To assess the impact of NOD2 deficiency on bacterial clearance and lung inflammation.

Main Methods:

  • In vitro phagocytosis assays using NOD2-deficient and wild-type alveolar macrophages and neutrophils.
  • In vivo mouse models of pneumococcal pneumonia using different S. pneumoniae strains (serotype 2, serotype 3, and an unencapsulated mutant).
  • Evaluation of bacterial load, dissemination, and lung inflammatory responses.

Main Results:

  • NOD2-deficient macrophages and neutrophils showed reduced in vitro phagocytosis of S. pneumoniae.
  • NOD2 deficiency did not alter outcomes in mice infected with virulent S. pneumoniae strains (D39 and 6303).
  • NOD2-deficient mice exhibited impaired clearance of the unencapsulated D39Δcps strain.

Conclusions:

  • NOD2 does not play a significant role in host defense against virulent S. pneumoniae pneumonia.
  • The capsule of S. pneumoniae appears to inhibit recognition by NOD2.
  • NOD2 may contribute to the clearance of specific pneumococcal strains, particularly unencapsulated variants.

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
4.1K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
3.5K
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
37
Regulation of Bacterial Virulence01:28

Regulation of Bacterial Virulence

Pathogenic bacteria employ a range of regulatory mechanisms to modulate the expression of virulence genes in response to environmental and host-derived signals. These mechanisms ensure that virulence factors are expressed only under favorable conditions, thereby optimizing infection and survival strategies.Mechanisms of Virulence RegulationKey regulatory strategies include:Two-Component Systems: These consist of a membrane-bound sensor kinase and a cytoplasmic response regulator. Environmental...
26
Colonisation of Pathogens01:25

Colonisation of Pathogens

Pathogen colonization of host tissues is a critical step in the development of infectious diseases. Various pathogenic microorganisms, including bacteria, fungi, viruses, and protozoa, have evolved complex strategies to attach to, invade, and persist within host environments. These mechanisms enable pathogens to establish infections, evade immune responses, and resist antimicrobial treatments.Attachment to Host CellsIn bacteria, colonization typically begins with adherence to host epithelial...
31
Defense Mechanism Against Infection01:26

Defense Mechanism Against Infection

Natural flora, body system defenses, and inflammation are natural barriers of the body against infectious agents regardless of previous exposure. Normal floras of the human body refer to the microbial population that colonizes the skin and mucous membranes.
In addition, many body organ systems have unique defenses against infection. The skin is an intact, multilayered surface preventing invasion by microorganisms unless impaired. Mucous membranes lining the mouth, nose, and eyelids are barriers...
11.0K